EP3978074
TERLÍPRESSÍN TIL AÐ MEÐHÖNDLA LIFRARNÝRNAHEILKENNI AF TEGUND 1
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.10.2015EP published:
6.3.2024EP application number:
21205752.5
EP translation filed:
30.4.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
21.10.2035Expiry date:
21.10.2026Next due date:
31.10.2026
Title in English:
TERLIPRESSIN FOR TREATING HEPATORENAL SYNDROME TYPE 1Language of the patent:
English
Timeline
Today
22.10.2015EP application
6.3.2024EP Publication
30.4.2024Translation submitted
15.6.2024Registration published
21.10.2026Expires
Owner
Name:
Mallinckrodt Pharmaceuticals Ireland LimitedAddress:
College Business & Technology Park Cruiserath, Blanchardstown, Dublin 15, IE
Inventor
Name:
JAMIL, KhurramAddress:
Pennsylvania, 18940, US
Name:
PAPPAS, Stephen ChrisAddress:
Texas, 77382, US
Name:
POTENZIANO, JimAddress:
New York, 13901, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201462068357 PDate:
24.10.2014Country:
US
Number:
201562151384 PDate:
22.4.2015Country:
US
Classification
Categories:
A61K 38/095, G01N 33/49, A61K 38/38, A61P 13/12
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 8.10.2024
Expires: 21.10.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 14.10.2025
Expires: 21.10.2026
Payer: Árnason Faktor ehf.